Parvoviral infection of endothelial cells and stromal fibroblasts: A possible pathogenetic role in scleroderma

Journal of Cutaneous Pathology

Volumn 31, Issue 1, 2004, Pages 43-50

  Magro, Cynthia M ^a   Nuovo, Gerard ^a   Ferri, Clodoveo ^b   Crowson, A Neil ^c   Giuggioli, Dilia ^b   Sebastiani, Marco ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CENTROMERE ANTIBODY; IMMUNOGLOBULIN M; MESSENGER RNA; PROTEIN; PROTEIN C5B 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; BONE MARROW; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LUNG DISEASE; MALE; MAST CELL; MYOCARDIAL DISEASE; PARVOVIRUS; PATHOGENESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCLERODERMA; SCREENING; SEROLOGY; SKIN BIOPSY; SKIN BLOOD VESSEL; STROMA; VIRUS INFECTION;

ADULT; AGED; CAPSID PROTEINS; COMPLEMENT MEMBRANE ATTACK COMPLEX; DNA, VIRAL; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, VIRAL; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1642521898     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0303-6987.2003.0143.x     Document Type: Article

References (31)

1. Ferri C, Valentini G, Cozzi F, et al. Systemic sclerosis: demographic, clinical and serological features and survival in 1012 Italian patients. Medicine 2002; 81: 139.
2. Ferri C, Zakrzewska K, Longombardo G, et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheum 1999; 17: 718.
3. Ferri C, Zakrzewska K, Giuggioli D, et al. Parvovirus B19 infection in the skin and bone marrow of systemic sclerosis patients. Arthritis Rheum 2000; 42: 1491 [Abstract].
4. Finkel TH, Torok TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994; 343: 1255.
5. Nikkari S, Mertsola J, Korvenranta H. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 1994; 37: 1707.
6. Veraldi S, Mancuso R, Rizzitelli G, et al. Henoch-Schonlein syndrome associated with human Parvovirus B19 primary infection. Eur J Dermatol 1999; 9: 232.
7. Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 2000; 27: 505.
8. Magro CM, Crowson AN, Dawood M, Nuovo GJ. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol 2002; 29: 1227.
9. Masi AT, Rodnan GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581.
10. Fridell E, Bekassy AN, Larsson B, Eriksson BM. Polymerase chain reaction with double primer pairs for detection of human parvovirus B19 induced aplastic crises in family outbreaks. Scand J Infect Dis 1992; 24: 275.
11. Nuovo GJ. PCR in situ hybridization: protocols and applications, 3rd edn. New York: Lippincott-Raven, 1997.
12. Holm JM, Hanson LK, Oxhoj H. Kawasaki disease associated with parvovirus B19 infection. Eur J Pediatr 1995; 154: 633.
13. Fukushige J, Takahashi N, Ueda K, et al. Kawasaki disease and human parvovirus B19 antibody: role of immunoglobulin therapy. Acta Paediatr Jpn 1995; 37: 758.
14. Lhote F, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment. Rheum Dis Clin North Am 1995; 21: 911.
15. Magro CM, Dawood MR, Crowson AN. The cutaneous manifestations of human parvovirus B19 infection. Hum Pathol 2000; 31: 488.
16. Diaz F, Collazos J. Glomerulonephritis and Henoch-Schoenlein purpura associated with acute parvovirus B19 infection. Clin Nephrol 2000; 53: 237.
17. Watanabe T, Oda Y. Henoch-Schonlein purpura nephritis associated with human parvovirus B19 infection. Pediatr Int 2000; 42: 94.
18. Gabriel SE, Espy M, Erdman DD, et al. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum 1999; 42: 1255.
19. Naides SJ. Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 1998; 24: 375.
20. Morelli S, Ferri C, Polettini E, et al. Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med 1995; 99: 255.
21. Ferri C, Latorraca A, Catapano G, et al. Increased plasma endothelin-1 immunoreactive levels in vasculitis: a clue to the use of endothelin-1 as a marker of vascular damage? J Hypertens Suppl 1993; 11: S142.
22. Sgonc R, Gruschwitz MS, Boeck G, et al. Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000; 43: 2550.
23. Crowson AN, Magro CM. The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 1996; 27: 15.
24. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262: 114.
25. Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis 1995; 172: 1198.
26. Sol N, Le Junter J, Vassias I. Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 1999; 73: 8762.
27. Pittoni V, Isenberg D. Apoptosis and antiphospholipid antibodies. Semin Arthritis Rheum 1998; 28: 163.
28. Levine JS, Koh JS, Subang R, Rauch J. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome. Exp Mol Pathol 1999; 66: 82.
29. Magro CM, Crowson AN, Regauer S. Mixed connective tissue disease. A clinical, histologic, and immunofluorescence study of eight cases. Am J Dermatopathol 1997; 19: 206.
30. Magro CM, Crowson AN. The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 1997; 24: 543.
31. White B. Immunopathogenesis of systemic sclerosis. Rheum Dis Clin North Am 1996; 22: 695.